Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Marham-e-Asfedaj vs Coal Tar/Salicylic Acid in Plaque Psoriasis
NCT07841314Phase 2Not yet recruiting
- Sponsor
- National Institute of Unani Medicine
- Start
- Apr 2027
- Primary completion
- Apr 2029
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in plaque psoriasis, sponsored by National Institute of Unani Medicine. Primary endpoint: Psoriasis Area Severity Index at 90 days. Planned start Apr 2027; status: not yet recruiting.
02
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07841314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07841314.